3,4-dihydroxyphenylglycolaldehyde has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, EH; Kang, SS; Liles, LC; Liu, X; Luo, HR; Manfredsson, FP; Weinshenker, D; Xiang, J; Yang, X; Ye, K | 1 |
| Burke, WJ; Chung, HD; Gillespie, KN; Li, SW; Schmitt, CA; Xia, P | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylglycolaldehyde and Alzheimer Disease
| Article | Year |
|---|---|
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
Topics: Adrenergic Neurons; Aged; Aged, 80 and over; Aldehydes; Alzheimer Disease; Animals; Catechols; Cell Line, Tumor; Female; HEK293 Cells; Humans; Locus Coeruleus; Male; Mice; Mice, Knockout; Middle Aged; Norepinephrine; Protein Aggregation, Pathological; tau Proteins | 2020 |
Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death.
Topics: Aged; Aldehydes; Alzheimer Disease; Catechols; Cell Count; Cell Death; Female; Humans; Locus Coeruleus; Male; Monoamine Oxidase; Neurons; Neurotoxins; Norepinephrine | 1999 |